{"id":66847,"date":"2022-08-17T09:45:34","date_gmt":"2022-08-17T07:45:34","guid":{"rendered":"https:\/\/packaging-journal.de\/?p=66847"},"modified":"2024-05-12T15:53:46","modified_gmt":"2024-05-12T13:53:46","slug":"gerresheimer-expands-production-in-the-usa","status":"publish","type":"post","link":"https:\/\/packaging-journal.de\/en\/gerresheimer-baut-produktion-in-den-usa-aus\/","title":{"rendered":"Gerresheimer expands production in the USA"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Gerresheimer is expanding its production, supply and logistics capacities for glass vials in the USA with an investment of USD 94 million. The company is thus creating capacity for a new glass moulding line.\u00a0<\/strong><\/p><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The project is supported by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) of the U.S. Department of Health and Human Services (HHS) and the Department of Defence (DOD). BARDA will Gerresheimer<\/a> up to USD 66 million for this project. The Investment is part of the global expansion plan and the strategy process<\/strong> formula G of Gerresheimer.<\/p><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Under the terms of the agreement, Gerresheimer will Annual production capacity at the plant in Morganton, North Carolina<\/strong> with type 1 vials (borosilicate glass and\/or aluminosilicate) and Gx Elite Glass Vials increase<\/strong>. Funding from BARDA, with contractual support from DOD's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND) and the Army Contracting Command (ACC), increases the capacity in the U.S. to provide rapid response to current vaccination campaigns against infectious diseases<\/strong>including against Covid-19. The expansion of the plant will further strengthen the company's leading market position in elite glass surfaces.<\/p>

\"\"<\/a><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\"We are pleased to support the U.S. government in strengthening its pharmaceutical supply chain for current and future healthcare emergencies. The agreement confirms our important role as a supplier of system-critical products such as pharmaceutical primary packaging solutions and drug delivery systems for the healthcare sector. This investment is part of our formula G strategy process and accelerates our growth in this important market.\"<\/p>

Dietmar Siemssen<\/strong>Chairman of the Management Board of Gerresheimer AG<\/p><\/blockquote><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

As part of the expansion, the existing plant in North Carolina will be replaced by the Installation of new vial moulding line and a new warehouse expanded<\/strong>. In addition, new offices are planned to accommodate the growing number of employees.<\/p>

The company endeavours to use the majority of its Sourcing raw materials from U.S. suppliers to improve the responsiveness, reliability, quality and integration of domestic supply chains.<\/strong> to ensure a sustainable future. The company is also taking sustainability principles into account during the modernisation and expansion work and is implementing measures to improve energy efficiency and reduce waste, among other things.<\/p>